Femasys (FEMY) Asset Writedowns and Impairment (2024 - 2025)
Femasys (FEMY) reported Asset Writedowns and Impairment of -$5000.0 for Q1 2025, down 600.0% on a YoY basis from $1000.0 in Q1 2024, and down 350.0% quarter-over-quarter from $2000.0 in Q4 2024.
Femasys (FEMY) Asset Writedowns and Impairment (2024 - 2025) Analysis & Trends
Femasys has reported Asset Writedowns and Impairment for 2 years, with the latest figure at -$5000.0 in Q1 2025.
- For the quarter ending Q1 2025, Asset Writedowns and Impairment fell 600.0% year-over-year to -$5000.0; the trailing twelve-month figure through Mar 2025 stood at -$2000.0 (changed N/A YoY), and the FY2024 full-year result was $8000.0, changed N/A from the prior year.
- Asset Writedowns and Impairment for Q1 2025 stood at -$5000.0, down from $2000.0 in the prior quarter.
- The five-year high for Asset Writedowns and Impairment was $2000.0 in Q4 2024, with the low at -$5000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Femasys | 254.59 Mn | 249.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -5,000.00 |
| Mar 31, 2025 | -5,000.00 |
| Dec 31, 2024 | 2,000.00 |
| Dec 31, 2024 | 2,000.00 |
| Mar 31, 2024 | 1,000.00 |
| Mar 31, 2024 | 1,000.00 |